Nationally and internationally renowned faculty provides a state-of-the-art update on the latest treatment options for patients with hepato-biliary and pancreatic cancers. The program is designed to provide a multidisciplinary overview on the importance of early diagnosis and treatment considerations, including surgery and new pharmacological agents, and how to incorporate these into clinical practice. There will also be a focus on emerging immuno-oncology and molecular profiling options.